This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
ContextVision AB (publ)
Q32020
10/22/2020
Ole Eikland
Head of Investor Relations
Welcome to this third quarter presentation for ContextVision. You are Fredrik Pahl, the CEO. I am Ole Eikland. The third quarter was a good quarter for ContextVision.
Fredrik Pahl
CEO
Could you give us some highlights? It was yet another progressive quarter for the company. We are following the launch plan within digital pathology with our first product for prostate cancer launched in the end of this last quarter. Sales is increasing compared to previous quarter which we cautiously take as a positive sign. Our x-ray sales continue to grow and we are maintaining solid financials.
Ole Eikland
Head of Investor Relations
But regarding the Inify, which is your first digital pathology product for screening of prostate cancer using deep learning and artificial intelligence, is it on track?
You're reading a preview of the 0L8Z.L Q3 2020 earnings call.
Free account.
Disclaimer